课题基金 / 基金详情

VIRAL CONTROL AND IMMUNE RECONSTITUTION IN HIV INFECTION

VIRAL CONTROL AND IMMUNE RECONSTITUTION IN HIV INFECTION
HIV 感染的病毒控制和免疫重建
批准号:
2517303
负责人:
Dani P. Bolognesi
金额:
$87.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 1999-08-31

项目摘要

项目成果

Dani P. Bolognesi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Any treatment strategy for HIV disease must confront a massive viral infection which is widely disseminated in blood, secondary lymphoid organs and other body compartments. It is now becoming apparent that these reservoirs exhibit different features in terms of viral burden and kinetics of virus and infected cell turnover. Recent estimates suggest that steady state levels of virus production are in the order of 10(9) viral particles per day with a plasma half life of two days. Correspondingly the production/destruction of HlV susceptible CD4 cells on average is also in the order of 10(9) cells per day. This places enormous stress on the immune system which must possess a remarkable regeneratiVe capacity in the face of the viral onslaught on the CD4 cell pool and other immune elements. Certain antiretroviral agents are able to reduce the viral burden by 99 to 99.9 percent and this decline is accompanied by a corresponding increase in CD4 cells. However, both effects are transient and reversed by drug resistant mutants which rapidly emerge and re-establish the steady state prior to treatment. There is considerable promise that combinations of anti-viral agents may significantly delay the appearance of drug resistant variants but one would still be faced with two major obstacles 1) the continuing presence of viral reservoirs that can spawn clinically relevant HlV variants able to repopulate the host and 2) the extent to which immune function in AIDS patients must be restored even if the virus can be controlled pharmacologically. The goals of this SPlRAT application are to reduce viral burden using combination inductive and maintenance anti-viral therapy. We will supplement the antiretrovirus therapy with alternative interventional strategies designed to reduce or eliminate residual viral reservoirs. Our major aim is then to reconstitute immune function through approximately HLA matched allografts of hematopoietic stem cells and thymus. This SPIRAT Program will include three Projects, two Scientific Cores and one Administrative Core.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--DEVELOPMENTAL CORE
  • 批准号:
    6217094
  • 项目类别:
  • 资助金额:
    $8.53万
  • 财政年份:
    1999
  • 负责人:
    Dani P. Bolognesi
  • 依托单位:
CORE--DEVELOPMENTAL CORE
  • 批准号:
    6099439
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1998
  • 负责人:
    Dani P. Bolognesi
  • 依托单位:
CORE--DEVELOPMENTAL CORE
  • 批准号:
    6234943
  • 项目类别:
  • 资助金额:
    $15.14万
  • 财政年份:
    1997
  • 负责人:
    Dani P. Bolognesi
  • 依托单位:
CENTRAL IMMUNOLOGY LAB FOR AIDS VACCINE CLINICAL TRIALS
  • 批准号:
    6158928
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1996
  • 负责人:
    Dani P. Bolognesi
  • 依托单位:
海外基金